Garnier hired to restructure French firm

What's GlaxoSmithKline's ex-CEO Jean-Pierre Garnier up to these days? Well, in addition to director and advisory roles he holds at United Technologies, Renault, and the sovereign fund Dubai Capital, Garnier is expected to "return to his French roots" as chief executive of the health and beauty company Pierre Fabre.

As you know, Garnier retired from GSK in May, leaving new CEO Andrew Witty in charge. His mandate at Fabre, the Financial Times reports, will be the restructuring of the company, which is located in southwest France. Garnier has plenty of experience at overhauls: He engineered a big one, with thousands of layoffs, just before turning over GSK's reins to Witty.

- see the FT story

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.